Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: AlienTech who wrote (10278)	6/30/1998 2:57:00 PM
From: VLAD	Read Replies (2) \| Respond to of 23519

Alien, When the investment community opens its eyes and realizes that Vivus will do well in the international markets and that script rates in the US will eventually recover then we will see more than just a doubling in share price. The Viagra hype seems to finally started to wane. New Viagra scripts have declined 5 weeks in a row now and will continue to do so. I figure that now that most impotent men have tried Viagra, the failures will slowly but surely trickle into the doctors office to give MUSE a crack. Also note that the FDA has finally appointed a special comission to look into all of the deaths and adverse reactions related to Viagra. I used to constantly see this commercial on TV where a lawyer was trying to recruit clients that had taken Fen-Phen. It's just a matter of time now before we see the same types of commercials regarding Viagra. It's going to get ugly--probably worse than the Dow Corning breast implant situation. Give it some time--3 more months sounds about right to me.